JAGUAR HEALTH, INC. Shareholders' Equity
JAGUAR HEALTH, INC. (JAGX) had Shareholders' Equity of $21.55 million as of 2021-09-30, per its 10-Q filed 2021-11-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-11-17
- 2021-09-30: Stockholders' Equity Attributable to Parent $21.55M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $31.79M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $31.89M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $17.20M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2021-09-30 | $21.55M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $31.79M 10-Q · filed 2021-11-17 | |
| 2021-03-31 | $31.89M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $17.20M 10-Q · filed 2021-11-17 | |
| 2020-09-30 | $7.81M 10-Q · filed 2021-11-17 | |
| 2020-06-30 | $1.54M 10-Q · filed 2021-11-17 | |
| 2020-03-31 | $6.23M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $10.67M 10-Q · filed 2021-11-17 | $10.67M 10-K · filed 2020-04-03 |
| 2019-09-30 | $11.38M 10-Q · filed 2020-11-16 | $11.38M 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$1.65M 10-Q · filed 2020-11-16 | -$1.64M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $6.79M 10-Q · filed 2020-08-13 | $6.80M 10-Q · filed 2019-05-21 |
| 2018-12-31 | $5.38M 10-K · filed 2021-03-31 | $5.38M 10-K · filed 2019-04-10 |
| 2018-09-30 | $10.32M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $14.02M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $21.01M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $17.26M 10-K · filed 2020-04-03 | |
| 2017-09-30 | $31.81M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | -$6.27M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$6.19M 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | -$2.45M 10-K · filed 2019-04-10 | |
| 2016-09-30 | -$273.04K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.57M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.65M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.40M 10-K · filed 2018-04-09 | |
| 2015-09-30 | $8.37M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $11.11M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$11.85M 10-Q · filed 2015-06-26 | |
| 2014-12-31 | -$8.24M 10-K · filed 2017-02-15 | |
| 2013-12-31 | -$434.85K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |